Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
ClearPoint Neuro, Inc. - SIC # 3840 -
Ticker
Exchange
SIC #
Website
Latest Ticker
CLPT
Nasdaq
3840
www.clearpointneuro.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for ClearPoint Neuro, Inc.
ClearPoint Neuro, Inc. Q3 2026 Earnings Call Summary
- Oct 29th, 2026 6:30 am
ClearPoint Neuro (CLPT) Q3 2026 Earnings Call Transcript
- Oct 28th, 2026 10:43 pm
What ClearPoint Neuro (CLPT) Said on Its Q3 Earnings Call
- Oct 28th, 2026 8:04 pm
ClearPoint Neuro, Inc. (CLPT) Reports Q3 Loss, Misses Revenue Estimates
- Oct 28th, 2026 4:30 pm
ClearPoint Neuro Reports Third Quarter 2026 Results
- Oct 28th, 2026 2:05 pm
Idexx Laboratories (IDXX) Reports Next Week: Wall Street Expects Earnings Growth
- Oct 26th, 2026 7:00 am
ClearPoint Neuro to Announce Third Quarter 2026 Results October 28, 2026
- Oct 14th, 2026 2:05 pm
AngioDynamics (ANGO) Reports Q1 Loss, Lags Revenue Estimates
- Oct 8th, 2026 4:15 am
ClearPoint Neuro Shares Fall 24% Following uniQure AMT-130 Trial Update
- Sep 29th, 2026 7:30 am
Alphatec (ATEC) Moves 19.7% Higher: Will This Strength Last?
- Sep 14th, 2026 4:12 am
ClearPoint Neuro (CLPT) Stock Sees Fair Value Cut As Analysts Factor In Heavier Investment
- Sep 4th, 2026 6:14 am
ClearPoint Neuro (CLPT) Q2 2026 Earnings Call Transcript
- Aug 10th, 2026 7:48 pm
ClearPoint Neuro, Inc. Q2 2026 Earnings Call Summary
- Aug 4th, 2026 6:30 am
ClearPoint Neuro (CLPT) Reports Q2 Earnings: What Key Metrics Have to Say
- Aug 3rd, 2026 5:00 pm
ClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Misses Revenue Estimates
- Aug 3rd, 2026 4:45 pm
ClearPoint Neuro Q2 Earnings Call Highlights
- Aug 3rd, 2026 4:03 pm
ClearPoint Neuro Reports Second Quarter 2026 Results
- Aug 3rd, 2026 2:05 pm
ClearPoint Neuro Congratulates Partner Aspen Neuroscience on FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Sasineprocel
- Jul 31st, 2026 2:05 pm
Scroll